Cogent Biosciences COGT
NASDAQ COGT
$31.66 -0.20 (-0.63%)
At close: Sep 29, 2026 · 4:00 PM EDT

Cogent Biosciences (COGT) Common Equity (2017 - 2026)

Updated

Cogent Biosciences' Common Equity was $532.39 million in Q2 2026, up 243.4% from $155.04 million a year earlier but down 12.4% from the prior quarter.

Analysis

Cogent Biosciences (COGT) Common Equity (2017 - 2026) Analysis & Trends

At the end of FY2025, Common Equity at Cogent Biosciences came in at $636.37 million, up 148.3% from FY2024.

  • Common Equity shows a five-year compound annual growth rate of 22.1% (FY2020 to FY2025).
  • In earlier years, Common Equity was $256.29 million in FY2024 (-0.6%), $257.8 million in FY2023 (+0.8%), $255.74 million in FY2022 (+19.4%) and $214.18 million in FY2021 (-8.7%).
  • Quarterly Common Equity has moved between $155.04 million (Q2 2025) and $636.37 million (Q4 2025) over five years.
  • Compared with a year earlier, Common Equity has increased for three straight quarters, with growth averaging 57.8% over the last eight quarters.
  • The best year-over-year quarter for Common Equity over five years was Q2 2026 (growth of 243.4%); the worst was Q2 2025 (a decline of 58.5%).
  • Per Business Quant data, COGT's Common Equity in the three quarters before Q2 2026 was $607.69 million (Q1 2026), $636.37 million (Q4 2025) and $302.46 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 84.97 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -5.94 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 41.98 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 41.95 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 50.37 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 11.69 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.83 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 85.49 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 20.25 Bn
10 Cogent Biosciences 5.47 Bn 5.47 Bn - 532.39 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 532.39 Mn
Mar 31, 2026 607.69 Mn
Dec 31, 2025 636.37 Mn
Sep 30, 2025 302.46 Mn
Jun 30, 2025 155.04 Mn
Mar 31, 2025 219.00 Mn
Dec 31, 2024 256.29 Mn
Sep 30, 2024 314.66 Mn
Jun 30, 2024 373.22 Mn
Mar 31, 2024 422.33 Mn
Dec 31, 2023 257.80 Mn
Sep 30, 2023 302.90 Mn
Jun 30, 2023 348.43 Mn
Mar 31, 2023 223.56 Mn
Dec 31, 2022 255.74 Mn
Sep 30, 2022 289.94 Mn
Jun 30, 2022 319.39 Mn
Mar 31, 2022 187.86 Mn
Dec 31, 2021 214.18 Mn
Sep 30, 2021 197.24 Mn
API Access

Cogent Biosciences Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=COGT&period=max&api_key=YOUR_API_KEY